• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀的溶解度增强:综述

Solubility enhancement of simvastatin: a review.

作者信息

Murtaza Ghulam

机构信息

Department of Pharmaceutical Sciences, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan.

出版信息

Acta Pol Pharm. 2012 Jul-Aug;69(4):581-90.

PMID:22876598
Abstract

Fairly soluble drugs in gastrointestinal (GI) media exhibit complete oral absorption, and thus good bioavailability. About 40% of drugs are not soluble in water in practice and therefore are slowly absorbed, which results in insufficient and uneven bioavailability and GI toxicity. Thus, most exigent phase of drug development practice particularly for oral dosage forms is the enhancement of drug solubility and thereby its oral bioavailability. Solubility, an important factor to achieve desired plasma level of drug for pharmacological response, is the phenomenon of dissolution of solid in liquid phase resulting in a homogenous system. This review describes various traditional and novel methodologies proposed for solubility enhancement of simvastatin, and ultimately improvement in its bioavailability. For simvastatin, solubility is a crucial rate limiting factor to achieve its desired level in systemic circulation for pharmacological response. Thus, problematic solubility of simvastatin is a main challenge for dosage form developing researchers. Various procedures, illustrated in this review, have been successfully employed to improve the simvastatin solubility for its bioavailability enhancement; however, successful improvement essentially depends on the assortment of technique. Among all the solubility enhancement techniques, solid dispersion method, in terms of ease and efficiency is most promising and routinely employed technique to resolve the solubility problems of simvastatin.

摘要

在胃肠道(GI)介质中溶解度适中的药物呈现出完全的口服吸收,因此具有良好的生物利用度。实际上,约40%的药物不溶于水,因此吸收缓慢,这导致生物利用度不足且不均匀,以及胃肠道毒性。因此,药物研发实践中,尤其是口服剂型最迫切的阶段是提高药物溶解度,进而提高其口服生物利用度。溶解度是实现药物达到药理学反应所需血浆水平的一个重要因素,它是固体在液相中溶解形成均匀体系的现象。本综述描述了为提高辛伐他汀溶解度并最终改善其生物利用度而提出的各种传统和新型方法。对于辛伐他汀来说,溶解度是在体循环中达到药理学反应所需水平的关键限速因素。因此,辛伐他汀存在的溶解度问题是剂型研发研究人员面临的主要挑战。本综述中阐述的各种方法已成功用于提高辛伐他汀的溶解度以增强其生物利用度;然而,成功的改善在本质上取决于技术的选择。在所有提高溶解度的技术中,就简便性和效率而言,固体分散法是解决辛伐他汀溶解度问题最有前景且常规使用的技术。

相似文献

1
Solubility enhancement of simvastatin: a review.辛伐他汀的溶解度增强:综述
Acta Pol Pharm. 2012 Jul-Aug;69(4):581-90.
2
Comparative evaluation of various solubility enhancement strategies for furosemide.呋塞米多种溶解度增强策略的比较评估
Pak J Pharm Sci. 2014 Jul;27(4):963-73.
3
Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics.酪蛋白酸盐包被的辛伐他汀-玉米醇溶蛋白纳米粒的优化:提高生物利用度及改善释放特性
Drug Des Devel Ther. 2015 Jan 23;9:655-62. doi: 10.2147/DDDT.S76194. eCollection 2015.
4
The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.辛伐他汀载脂纳米粒提高大鼠口服生物利用度的特点及机制。
Int J Pharm. 2010 Jul 15;394(1-2):147-53. doi: 10.1016/j.ijpharm.2010.04.039. Epub 2010 May 8.
5
Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs.合理的配方开发和 SMEDDS 的体外评估用于口服递药的水溶性差的药物。
Eur J Pharm Sci. 2012 Aug 15;46(5):508-15. doi: 10.1016/j.ejps.2012.04.001. Epub 2012 Apr 10.
6
Preparation and characterization of solid dispersion of simvastatin.辛伐他汀固体分散体的制备与表征。
Drug Dev Ind Pharm. 2010 Nov;36(11):1348-55. doi: 10.3109/03639041003801901.
7
Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.辛伐他汀/二甲基-β-环糊精复合物的制备、表征及其在大鼠体内的药代动力学
Acta Pharm. 2018 Jun 1;68(2):145-157. doi: 10.2478/acph-2018-0016.
8
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.用于提高辛伐他汀在比格犬体内口服生物利用度的自微乳化药物递送系统(SMEDDS)的研发。
Int J Pharm. 2004 Apr 15;274(1-2):65-73. doi: 10.1016/j.ijpharm.2003.12.028.
9
Preparation and statistical optimization of alginate based stomach specific floating microcapsules of simvastatin.辛伐他汀海藻酸盐基胃内特定漂浮微胶囊的制备及统计优化
Acta Pol Pharm. 2012 Jul-Aug;69(4):751-61.
10
Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.含阿托伐他汀的自微乳化药物递送系统(SMEDDS)的制备与评价
J Pharm Pharmacol. 2006 Sep;58(9):1183-91. doi: 10.1211/jpp.58.9.0004.

引用本文的文献

1
The Application of Mesoporous Silica Nanoparticles in Enhancing the Efficacy of Anti-Atherosclerosis Therapies: A Review.介孔二氧化硅纳米颗粒在增强抗动脉粥样硬化治疗效果中的应用:综述
Int J Nanomedicine. 2025 Aug 10;20:9825-9856. doi: 10.2147/IJN.S538100. eCollection 2025.
2
Development of olanzapine solid dispersion by spray drying technique using screening design for solubility enhancement.采用筛选设计通过喷雾干燥技术制备奥氮平固体分散体以提高溶解度
ADMET DMPK. 2023 Oct 6;11(4):615-627. doi: 10.5599/admet.1998. eCollection 2023.
3
Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders.
非诺贝特-辛伐他汀固体分散体在开发用于治疗脂质紊乱的固定剂量制剂中的筛选。
Pharmaceutics. 2023 Feb 10;15(2):603. doi: 10.3390/pharmaceutics15020603.
4
Poly (l-lactic acid)-based modified nanofibrous membrane with dual drug release capability for GBR application.用于 GBR 应用的具有双重药物释放能力的聚(L-乳酸)基改性纳米纤维膜。
Int J Biol Macromol. 2023 Mar 15;231:123201. doi: 10.1016/j.ijbiomac.2023.123201. Epub 2023 Jan 12.
5
Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr-/-Mice.辛伐他汀-依折麦布共无定形制剂:在低密度脂蛋白受体基因敲除小鼠中增强的物理稳定性、生物利用度及降胆固醇作用
Pharmaceutics. 2022 Jun 13;14(6):1258. doi: 10.3390/pharmaceutics14061258.
6
Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations.依折麦布-辛伐他汀固体分散体在固定剂量复方制剂研发中的处方前研究
Pharmaceutics. 2022 Apr 22;14(5):912. doi: 10.3390/pharmaceutics14050912.
7
Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension.用于肺动脉高压潜在应用的辛伐他汀纳米颗粒干粉制剂
Pharmaceutics. 2022 Apr 20;14(5):895. doi: 10.3390/pharmaceutics14050895.
8
Incorporation of simvastatin in PLLA membranes for guided bone regeneration: effect of thermal treatment on simvastatin release.将辛伐他汀掺入聚左旋乳酸膜用于引导性骨再生:热处理对辛伐他汀释放的影响。
RSC Adv. 2018 Aug 10;8(50):28546-28554. doi: 10.1039/c8ra04397c. eCollection 2018 Aug 7.
9
A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.辛伐他汀-阿霉素脂质体的开发筛选研究,一种在结肠癌治疗中具有未来前景的联合制剂。
Pharmaceutics. 2021 Sep 22;13(10):1526. doi: 10.3390/pharmaceutics13101526.
10
Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.采用一步法无有机溶剂超临界流体工艺制备辛伐他汀与 Soluplus 的固体分散体以提高药物溶解度和溶出速率
Pharmaceuticals (Basel). 2021 Aug 25;14(9):846. doi: 10.3390/ph14090846.